Childhood cancer in Sweden during the COVID-19 pandemic: Temporal patterns in incidence and survival in a nationwide register-based cohort study
Overall childhood cancer incidence and survival in Sweden showed no major changes during the COVID-19 pandemic. Fluctuations in diagnostic-group-specific incidence may reflect delayed diagnoses or shifts in disease triggers; however, the timing of the ALL decline and the lack of AML rebound challenge this interpretation. Stable or improved survival suggests that any disruptions were not associated with poorer survival up to 1 year after diagnosis.
Authors
- Giorgio Tettamanti
- Hanna Mogensen (ORCID: https://orcid.org/0000-0001-5195-8065)
- Kleopatra Georgantzi (ORCID: https://orcid.org/0000-0001-9304-6144)
- Javier Louro (ORCID: https://orcid.org/0000-0002-2985-3301)
- Päivi M. Lähteenmäki (ORCID: https://orcid.org/0000-0002-5500-9606)
- Mats Heyman
- Maria Feychting
- Friederike Erdmann
- Anna Nilsson
- Christina-Evmorfia Kampitsi
Institutions
- Uppsala University (SE)
- Johannes Gutenberg University Mainz (DE)
- Karolinska Institutet (SE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Leibniz Institute for Prevention Research and Epidemiology - BIPS (DE)
Publication Details
- Journal
- PLoS Medicine
- Published
- 2026-03-05
- DOI
- https://doi.org/10.1371/journal.pmed.1004934
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vetenskapsrådet
- Barncancerfonden